Refer to Instructions for Use to ensure safe injections and to review risks. 1 Saraf, et al (2024). An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback